2025 annual financial data

Dyne Therapeutics 2025 Net margin

Dyne Therapeutics 2025 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -468,184,000 USD and net income was -446,214,000 USD.
Operating cash flow was -403,207,000 USD.

Get free Dyne Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-468,184,000 USD
Net income
-446,214,000 USD
Operating cash flow
-403,207,000 USD